Frazier Life Sciences Public Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS)

Filing Manager
Frazier Life Sciences Public Fund, L.P.
Reporting Manager
Frazier Life Sciences Public Fund, L.P.
Security
Erasca, Inc. Common Stock, $0.0001 par value per share
Symbol
ERAS
Shares outstanding
283,750,057 shares
Disclosed Ownership
15,038,753 shares
Ownership
5.3%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 13:10:13 UTC
Date of event
30 Jun 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Frazier Life Sciences Public Fund, L.P. disclosed 5.3% ownership in Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS) on 30 Jun 2025."

Quick Takeaways

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS).
  • Disclosed ownership: 5.3%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Aug 2025, 13:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (17)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 5.3% 15,038,753 0 15,038,753 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
FHMLSP, L.P. 5.3% 15,038,753 0 15,038,753 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
FHMLSP, L.L.C. 5.3% 15,038,753 0 15,038,753 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C.
Frazier Life Sciences Public Overage Fund, L.P. 0.8% 2,405,634 0 2,405,634 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P.
FHMLSP Overage, L.P. 0.8% 2,405,634 0 2,405,634 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P.
FHMLSP Overage, L.L.C. 0.8% 2,405,634 0 2,405,634 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C.
Frazier Life Sciences X, L.P. 0.6% 1,674,681 0 1,674,681 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
FHMLS X, L.P. 0.6% 1,674,681 0 1,674,681 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
FHMLS X, L.L.C. 0.6% 1,674,681 0 1,674,681 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C.
Frazier Life Sciences XI, L.P. 1.3% 3,610,368 0 3,610,368 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
FHMLS XI, L.P. 1.3% 3,610,368 0 3,610,368 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
FHMLS XI, L.L.C. 1.3% 3,610,368 0 3,610,368 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
James N. Topper 0.6% 1,674,681 0 1,674,681 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Patrick J. Heron 0.6% 1,674,681 0 1,674,681 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Albert Cha 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
James Brush 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
Daniel Estes 0% 0 0 0 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022

Sponsored